1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global In-Vitro Cancer Diagnostics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Instruments 1.2.3 Reagents and Kits 1.3 Market by Application 1.3.1 Global In-Vitro Cancer Diagnostics Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Laboratories 1.3.3 Hospitals 1.3.4 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global In-Vitro Cancer Diagnostics Market Perspective (2016-2027) 2.2 In-Vitro Cancer Diagnostics Growth Trends by Regions 2.2.1 In-Vitro Cancer Diagnostics Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 In-Vitro Cancer Diagnostics Historic Market Share by Regions (2016-2021) 2.2.3 In-Vitro Cancer Diagnostics Forecasted Market Size by Regions (2022-2027) 2.3 In-Vitro Cancer Diagnostics Industry Dynamic 2.3.1 In-Vitro Cancer Diagnostics Market Trends 2.3.2 In-Vitro Cancer Diagnostics Market Drivers 2.3.3 In-Vitro Cancer Diagnostics Market Challenges 2.3.4 In-Vitro Cancer Diagnostics Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top In-Vitro Cancer Diagnostics Players by Revenue 3.1.1 Global Top In-Vitro Cancer Diagnostics Players by Revenue (2016-2021) 3.1.2 Global In-Vitro Cancer Diagnostics Revenue Market Share by Players (2016-2021) 3.2 Global In-Vitro Cancer Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by In-Vitro Cancer Diagnostics Revenue 3.4 Global In-Vitro Cancer Diagnostics Market Concentration Ratio 3.4.1 Global In-Vitro Cancer Diagnostics Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by In-Vitro Cancer Diagnostics Revenue in 2020 3.5 In-Vitro Cancer Diagnostics Key Players Head office and Area Served 3.6 Key Players In-Vitro Cancer Diagnostics Product Solution and Service 3.7 Date of Enter into In-Vitro Cancer Diagnostics Market 3.8 Mergers & Acquisitions, Expansion Plans 4 In-Vitro Cancer Diagnostics Breakdown Data by Type 4.1 Global In-Vitro Cancer Diagnostics Historic Market Size by Type (2016-2021) 4.2 Global In-Vitro Cancer Diagnostics Forecasted Market Size by Type (2022-2027) 5 In-Vitro Cancer Diagnostics Breakdown Data by Application 5.1 Global In-Vitro Cancer Diagnostics Historic Market Size by Application (2016-2021) 5.2 Global In-Vitro Cancer Diagnostics Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America In-Vitro Cancer Diagnostics Market Size (2016-2027) 6.2 North America In-Vitro Cancer Diagnostics Market Size by Type 6.2.1 North America In-Vitro Cancer Diagnostics Market Size by Type (2016-2021) 6.2.2 North America In-Vitro Cancer Diagnostics Market Size by Type (2022-2027) 6.2.3 North America In-Vitro Cancer Diagnostics Market Size by Type (2016-2027) 6.3 North America In-Vitro Cancer Diagnostics Market Size by Application 6.3.1 North America In-Vitro Cancer Diagnostics Market Size by Application (2016-2021) 6.3.2 North America In-Vitro Cancer Diagnostics Market Size by Application (2022-2027) 6.3.3 North America In-Vitro Cancer Diagnostics Market Size by Application (2016-2027) 6.4 North America In-Vitro Cancer Diagnostics Market Size by Country 6.4.1 North America In-Vitro Cancer Diagnostics Market Size by Country (2016-2021) 6.4.2 North America In-Vitro Cancer Diagnostics Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe In-Vitro Cancer Diagnostics Market Size (2016-2027) 7.2 Europe In-Vitro Cancer Diagnostics Market Size by Type 7.2.1 Europe In-Vitro Cancer Diagnostics Market Size by Type (2016-2021) 7.2.2 Europe In-Vitro Cancer Diagnostics Market Size by Type (2022-2027) 7.2.3 Europe In-Vitro Cancer Diagnostics Market Size by Type (2016-2027) 7.3 Europe In-Vitro Cancer Diagnostics Market Size by Application 7.3.1 Europe In-Vitro Cancer Diagnostics Market Size by Application (2016-2021) 7.3.2 Europe In-Vitro Cancer Diagnostics Market Size by Application (2022-2027) 7.3.3 Europe In-Vitro Cancer Diagnostics Market Size by Application (2016-2027) 7.4 Europe In-Vitro Cancer Diagnostics Market Size by Country 7.4.1 Europe In-Vitro Cancer Diagnostics Market Size by Country (2016-2021) 7.4.2 Europe In-Vitro Cancer Diagnostics Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific In-Vitro Cancer Diagnostics Market Size (2016-2027) 8.2 Asia-Pacific In-Vitro Cancer Diagnostics Market Size by Type 8.2.1 Asia-Pacific In-Vitro Cancer Diagnostics Market Size by Type (2016-2021) 8.2.2 Asia-Pacific In-Vitro Cancer Diagnostics Market Size by Type (2022-2027) 8.2.3 Asia-Pacific In-Vitro Cancer Diagnostics Market Size by Type (2016-2027) 8.3 Asia-Pacific In-Vitro Cancer Diagnostics Market Size by Application 8.3.1 Asia-Pacific In-Vitro Cancer Diagnostics Market Size by Application (2016-2021) 8.3.2 Asia-Pacific In-Vitro Cancer Diagnostics Market Size by Application (2022-2027) 8.3.3 Asia-Pacific In-Vitro Cancer Diagnostics Market Size by Application (2016-2027) 8.4 Asia-Pacific In-Vitro Cancer Diagnostics Market Size by Region 8.4.1 Asia-Pacific In-Vitro Cancer Diagnostics Market Size by Region (2016-2021) 8.4.2 Asia-Pacific In-Vitro Cancer Diagnostics Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America In-Vitro Cancer Diagnostics Market Size (2016-2027) 9.2 Latin America In-Vitro Cancer Diagnostics Market Size by Type 9.2.1 Latin America In-Vitro Cancer Diagnostics Market Size by Type (2016-2021) 9.2.2 Latin America In-Vitro Cancer Diagnostics Market Size by Type (2022-2027) 9.2.3 Latin America In-Vitro Cancer Diagnostics Market Size by Type (2016-2027) 9.3 Latin America In-Vitro Cancer Diagnostics Market Size by Application 9.3.1 Latin America In-Vitro Cancer Diagnostics Market Size by Application (2016-2021) 9.3.2 Latin America In-Vitro Cancer Diagnostics Market Size by Application (2022-2027) 9.3.3 Latin America In-Vitro Cancer Diagnostics Market Size by Application (2016-2027) 9.4 Latin America In-Vitro Cancer Diagnostics Market Size by Country 9.4.1 Latin America In-Vitro Cancer Diagnostics Market Size by Country (2016-2021) 9.4.2 Latin America In-Vitro Cancer Diagnostics Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa In-Vitro Cancer Diagnostics Market Size (2016-2027) 10.2 Middle East & Africa In-Vitro Cancer Diagnostics Market Size by Type 10.2.1 Middle East & Africa In-Vitro Cancer Diagnostics Market Size by Type (2016-2021) 10.2.2 Middle East & Africa In-Vitro Cancer Diagnostics Market Size by Type (2022-2027) 10.2.3 Middle East & Africa In-Vitro Cancer Diagnostics Market Size by Type (2016-2027) 10.3 Middle East & Africa In-Vitro Cancer Diagnostics Market Size by Application 10.3.1 Middle East & Africa In-Vitro Cancer Diagnostics Market Size by Application (2016-2021) 10.3.2 Middle East & Africa In-Vitro Cancer Diagnostics Market Size by Application (2022-2027) 10.3.3 Middle East & Africa In-Vitro Cancer Diagnostics Market Size by Application (2016-2027) 10.4 Middle East & Africa In-Vitro Cancer Diagnostics Market Size by Country 10.4.1 Middle East & Africa In-Vitro Cancer Diagnostics Market Size by Country (2016-2021) 10.4.2 Middle East & Africa In-Vitro Cancer Diagnostics Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 MDx Health Quest Diagnostics 11.1.1 MDx Health Quest Diagnostics Company Details 11.1.2 MDx Health Quest Diagnostics Business Overview 11.1.3 MDx Health Quest Diagnostics In-Vitro Cancer Diagnostics Introduction 11.1.4 MDx Health Quest Diagnostics Revenue in In-Vitro Cancer Diagnostics Business (2016-2021) 11.1.5 MDx Health Quest Diagnostics Recent Development 11.2 R-Biopharm AG 11.2.1 R-Biopharm AG Company Details 11.2.2 R-Biopharm AG Business Overview 11.2.3 R-Biopharm AG In-Vitro Cancer Diagnostics Introduction 11.2.4 R-Biopharm AG Revenue in In-Vitro Cancer Diagnostics Business (2016-2021) 11.2.5 R-Biopharm AG Recent Development 11.3 Signature Diagnostics 11.3.1 Signature Diagnostics Company Details 11.3.2 Signature Diagnostics Business Overview 11.3.3 Signature Diagnostics In-Vitro Cancer Diagnostics Introduction 11.3.4 Signature Diagnostics Revenue in In-Vitro Cancer Diagnostics Business (2016-2021) 11.3.5 Signature Diagnostics Recent Development 11.4 Siemens Healthcare 11.4.1 Siemens Healthcare Company Details 11.4.2 Siemens Healthcare Business Overview 11.4.3 Siemens Healthcare In-Vitro Cancer Diagnostics Introduction 11.4.4 Siemens Healthcare Revenue in In-Vitro Cancer Diagnostics Business (2016-2021) 11.4.5 Siemens Healthcare Recent Development 11.5 Randox Laboratories 11.5.1 Randox Laboratories Company Details 11.5.2 Randox Laboratories Business Overview 11.5.3 Randox Laboratories In-Vitro Cancer Diagnostics Introduction 11.5.4 Randox Laboratories Revenue in In-Vitro Cancer Diagnostics Business (2016-2021) 11.5.5 Randox Laboratories Recent Development 11.6 Epigenomics AG 11.6.1 Epigenomics AG Company Details 11.6.2 Epigenomics AG Business Overview 11.6.3 Epigenomics AG In-Vitro Cancer Diagnostics Introduction 11.6.4 Epigenomics AG Revenue in In-Vitro Cancer Diagnostics Business (2016-2021) 11.6.5 Epigenomics AG Recent Development 11.7 Beckman Coulter 11.7.1 Beckman Coulter Company Details 11.7.2 Beckman Coulter Business Overview 11.7.3 Beckman Coulter In-Vitro Cancer Diagnostics Introduction 11.7.4 Beckman Coulter Revenue in In-Vitro Cancer Diagnostics Business (2016-2021) 11.7.5 Beckman Coulter Recent Development 11.8 Abbott Laboratories 11.8.1 Abbott Laboratories Company Details 11.8.2 Abbott Laboratories Business Overview 11.8.3 Abbott Laboratories In-Vitro Cancer Diagnostics Introduction 11.8.4 Abbott Laboratories Revenue in In-Vitro Cancer Diagnostics Business (2016-2021) 11.8.5 Abbott Laboratories Recent Development 11.9 Burning Rock 11.9.1 Burning Rock Company Details 11.9.2 Burning Rock Business Overview 11.9.3 Burning Rock In-Vitro Cancer Diagnostics Introduction 11.9.4 Burning Rock Revenue in In-Vitro Cancer Diagnostics Business (2016-2021) 11.9.5 Burning Rock Recent Development 11.10 Novogene 11.10.1 Novogene Company Details 11.10.2 Novogene Business Overview 11.10.3 Novogene In-Vitro Cancer Diagnostics Introduction 11.10.4 Novogene Revenue in In-Vitro Cancer Diagnostics Business (2016-2021) 11.10.5 Novogene Recent Development 11.11 Geneseeq 11.11.1 Geneseeq Company Details 11.11.2 Geneseeq Business Overview 11.11.3 Geneseeq In-Vitro Cancer Diagnostics Introduction 11.11.4 Geneseeq Revenue in In-Vitro Cancer Diagnostics Business (2016-2021) 11.11.5 Geneseeq Recent Development 11.12 Amoy Diagnostics Co.,Ltd. 11.12.1 Amoy Diagnostics Co.,Ltd. Company Details 11.12.2 Amoy Diagnostics Co.,Ltd. Business Overview 11.12.3 Amoy Diagnostics Co.,Ltd. In-Vitro Cancer Diagnostics Introduction 11.12.4 Amoy Diagnostics Co.,Ltd. Revenue in In-Vitro Cancer Diagnostics Business (2016-2021) 11.12.5 Amoy Diagnostics Co.,Ltd. Recent Development 11.13 Daan Gene 11.13.1 Daan Gene Company Details 11.13.2 Daan Gene Business Overview 11.13.3 Daan Gene In-Vitro Cancer Diagnostics Introduction 11.13.4 Daan Gene Revenue in In-Vitro Cancer Diagnostics Business (2016-2021) 11.13.5 Daan Gene Recent Development 11.14 Fosun Pharma 11.14.1 Fosun Pharma Company Details 11.14.2 Fosun Pharma Business Overview 11.14.3 Fosun Pharma In-Vitro Cancer Diagnostics Introduction 11.14.4 Fosun Pharma Revenue in In-Vitro Cancer Diagnostics Business (2016-2021) 11.14.5 Fosun Pharma Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global In-Vitro Cancer Diagnostics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Instruments Table 3. Key Players of Reagents and Kits Table 4. Global In-Vitro Cancer Diagnostics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 5. Global In-Vitro Cancer Diagnostics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 6. Global In-Vitro Cancer Diagnostics Market Size by Regions (2016-2021) & (US$ Million) Table 7. Global In-Vitro Cancer Diagnostics Market Share by Regions (2016-2021) Table 8. Global In-Vitro Cancer Diagnostics Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 9. Global In-Vitro Cancer Diagnostics Market Share by Regions (2022-2027) Table 10. In-Vitro Cancer Diagnostics Market Trends Table 11. In-Vitro Cancer Diagnostics Market Drivers Table 12. In-Vitro Cancer Diagnostics Market Challenges Table 13. In-Vitro Cancer Diagnostics Market Restraints Table 14. Global In-Vitro Cancer Diagnostics Revenue by Players (2016-2021) & (US$ Million) Table 15. Global In-Vitro Cancer Diagnostics Market Share by Players (2016-2021) Table 16. Global Top In-Vitro Cancer Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in In-Vitro Cancer Diagnostics as of 2020) Table 17. Ranking of Global Top In-Vitro Cancer Diagnostics Companies by Revenue (US$ Million) in 2020 Table 18. Global 5 Largest Players Market Share by In-Vitro Cancer Diagnostics Revenue (CR5 and HHI) & (2016-2021) Table 19. Key Players Headquarters and Area Served Table 20. Key Players In-Vitro Cancer Diagnostics Product Solution and Service Table 21. Date of Enter into In-Vitro Cancer Diagnostics Market Table 22. Mergers & Acquisitions, Expansion Plans Table 23. Global In-Vitro Cancer Diagnostics Market Size by Type (2016-2021) (US$ Million) Table 24. Global In-Vitro Cancer Diagnostics Revenue Market Share by Type (2016-2021) Table 25. Global In-Vitro Cancer Diagnostics Forecasted Market Size by Type (2022-2027) (US$ Million) Table 26. Global In-Vitro Cancer Diagnostics Revenue Market Share by Type (2022-2027) & (US$ Million) Table 27. Global In-Vitro Cancer Diagnostics Market Size Share by Application (2016-2021) & (US$ Million) Table 28. Global In-Vitro Cancer Diagnostics Revenue Market Share by Application (2016-2021) Table 29. Global In-Vitro Cancer Diagnostics Forecasted Market Size by Application (2022-2027) (US$ Million) Table 30. Global In-Vitro Cancer Diagnostics Revenue Market Share by Application (2022-2027) & (US$ Million) Table 31. North America In-Vitro Cancer Diagnostics Market Size by Type (2016-2021) (US$ Million) Table 32. North America In-Vitro Cancer Diagnostics Market Size by Type (2022-2027) & (US$ Million) Table 33. North America In-Vitro Cancer Diagnostics Market Size by Application (2016-2021) (US$ Million) Table 34. North America In-Vitro Cancer Diagnostics Market Size by Application (2022-2027) & (US$ Million) Table 35. North America In-Vitro Cancer Diagnostics Market Size by Country (2016-2021) & (US$ Million) Table 36. North America In-Vitro Cancer Diagnostics Market Size by Country (2022-2027) & (US$ Million) Table 37. Europe In-Vitro Cancer Diagnostics Market Size by Type (2016-2021) (US$ Million) Table 38. Europe In-Vitro Cancer Diagnostics Market Size by Type (2022-2027) & (US$ Million) Table 39. Europe In-Vitro Cancer Diagnostics Market Size by Application (2016-2021) (US$ Million) Table 40. Europe In-Vitro Cancer Diagnostics Market Size by Application (2022-2027) & (US$ Million) Table 41. Europe In-Vitro Cancer Diagnostics Market Size by Country (2016-2021) & (US$ Million) Table 42. Europe In-Vitro Cancer Diagnostics Market Size by Country (2022-2027) & (US$ Million) Table 43. Asia-Pacific In-Vitro Cancer Diagnostics Market Size by Type (2016-2021) (US$ Million) Table 44. Asia-Pacific In-Vitro Cancer Diagnostics Market Size by Type (2022-2027) & (US$ Million) Table 45. Asia-Pacific In-Vitro Cancer Diagnostics Market Size by Application (2016-2021) (US$ Million) Table 46. Asia-Pacific In-Vitro Cancer Diagnostics Market Size by Application (2022-2027) & (US$ Million) Table 47. Asia-Pacific In-Vitro Cancer Diagnostics Market Size by Region (2016-2021) & (US$ Million) Table 48. Asia-Pacific In-Vitro Cancer Diagnostics Market Size by Region (2022-2027) & (US$ Million) Table 49. Latin America In-Vitro Cancer Diagnostics Market Size by Type (2016-2021) (US$ Million) Table 50. Latin America In-Vitro Cancer Diagnostics Market Size by Type (2022-2027) & (US$ Million) Table 51. Latin America In-Vitro Cancer Diagnostics Market Size by Application (2016-2021) (US$ Million) Table 52. Latin America In-Vitro Cancer Diagnostics Market Size by Application (2022-2027) & (US$ Million) Table 53. Latin America In-Vitro Cancer Diagnostics Market Size by Country (2016-2021) & (US$ Million) Table 54. Latin America In-Vitro Cancer Diagnostics Market Size by Country (2022-2027) & (US$ Million) Table 55. Middle East & Africa In-Vitro Cancer Diagnostics Market Size by Type (2016-2021) (US$ Million) Table 56. Middle East & Africa In-Vitro Cancer Diagnostics Market Size by Type (2022-2027) & (US$ Million) Table 57. Middle East & Africa In-Vitro Cancer Diagnostics Market Size by Application (2016-2021) (US$ Million) Table 58. Middle East & Africa In-Vitro Cancer Diagnostics Market Size by Application (2022-2027) & (US$ Million) Table 59. Middle East & Africa In-Vitro Cancer Diagnostics Market Size by Country (2016-2021) & (US$ Million) Table 60. Middle East & Africa In-Vitro Cancer Diagnostics Market Size by Country (2022-2027) & (US$ Million) Table 61. MDx Health Quest Diagnostics Company Details Table 62. MDx Health Quest Diagnostics Business Overview Table 63. MDx Health Quest Diagnostics In-Vitro Cancer Diagnostics Product Table 64. MDx Health Quest Diagnostics Revenue in In-Vitro Cancer Diagnostics Business (2016-2021) & (US$ Million) Table 65. MDx Health Quest Diagnostics Recent Development Table 66. R-Biopharm AG Company Details Table 67. R-Biopharm AG Business Overview Table 68. R-Biopharm AG In-Vitro Cancer Diagnostics Product Table 69. R-Biopharm AG Revenue in In-Vitro Cancer Diagnostics Business (2016-2021) & (US$ Million) Table 70. R-Biopharm AG Recent Development Table 71. Signature Diagnostics Company Details Table 72. Signature Diagnostics Business Overview Table 73. Signature Diagnostics In-Vitro Cancer Diagnostics Product Table 74. Signature Diagnostics Revenue in In-Vitro Cancer Diagnostics Business (2016-2021) & (US$ Million) Table 75. Signature Diagnostics Recent Development Table 76. Siemens Healthcare Company Details Table 77. Siemens Healthcare Business Overview Table 78. Siemens Healthcare In-Vitro Cancer Diagnostics Product Table 79. Siemens Healthcare Revenue in In-Vitro Cancer Diagnostics Business (2016-2021) & (US$ Million) Table 80. Siemens Healthcare Recent Development Table 81. Randox Laboratories Company Details Table 82. Randox Laboratories Business Overview Table 83. Randox Laboratories In-Vitro Cancer Diagnostics Product Table 84. Randox Laboratories Revenue in In-Vitro Cancer Diagnostics Business (2016-2021) & (US$ Million) Table 85. Randox Laboratories Recent Development Table 86. Epigenomics AG Company Details Table 87. Epigenomics AG Business Overview Table 88. Epigenomics AG In-Vitro Cancer Diagnostics Product Table 89. Epigenomics AG Revenue in In-Vitro Cancer Diagnostics Business (2016-2021) & (US$ Million) Table 90. Epigenomics AG Recent Development Table 91. Beckman Coulter Company Details Table 92. Beckman Coulter Business Overview Table 93. Beckman Coulter In-Vitro Cancer Diagnostics Product Table 94. Beckman Coulter Revenue in In-Vitro Cancer Diagnostics Business (2016-2021) & (US$ Million) Table 95. Beckman Coulter Recent Development Table 96. Abbott Laboratories Company Details Table 97. Abbott Laboratories Business Overview Table 98. Abbott Laboratories Revenue in In-Vitro Cancer Diagnostics Business (2016-2021) & (US$ Million) Table 99. Abbott Laboratories Recent Development Table 100. Burning Rock Company Details Table 101. Burning Rock Business Overview Table 102. Burning Rock In-Vitro Cancer Diagnostics Product Table 103. Burning Rock Revenue in In-Vitro Cancer Diagnostics Business (2016-2021) & (US$ Million) Table 104. Burning Rock Recent Development Table 105. Novogene Company Details Table 106. Novogene Business Overview Table 107. Novogene In-Vitro Cancer Diagnostics Product Table 108. Novogene Revenue in In-Vitro Cancer Diagnostics Business (2016-2021) & (US$ Million) Table 109. Novogene Recent Development Table 110. Geneseeq Company Details Table 111. Geneseeq Business Overview Table 112. Geneseeq In-Vitro Cancer Diagnostics Product Table 113. Geneseeq Revenue in In-Vitro Cancer Diagnostics Business (2016-2021) & (US$ Million) Table 114. Geneseeq Recent Development Table 115. Amoy Diagnostics Co.,Ltd. Company Details Table 116. Amoy Diagnostics Co.,Ltd. Business Overview Table 117. Amoy Diagnostics Co.,Ltd. In-Vitro Cancer Diagnostics Product Table 118. Amoy Diagnostics Co.,Ltd. Revenue in In-Vitro Cancer Diagnostics Business (2016-2021) & (US$ Million) Table 119. Amoy Diagnostics Co.,Ltd. Recent Development Table 120. Daan Gene Company Details Table 121. Daan Gene Business Overview Table 122. Daan Gene In-Vitro Cancer Diagnostics Product Table 123. Daan Gene Revenue in In-Vitro Cancer Diagnostics Business (2016-2021) & (US$ Million) Table 124. Daan Gene Recent Development Table 125. Fosun Pharma Company Details Table 126. Fosun Pharma Business Overview Table 127. Fosun Pharma In-Vitro Cancer Diagnostics Product Table 128. Fosun Pharma Revenue in In-Vitro Cancer Diagnostics Business (2016-2021) & (US$ Million) Table 129. Fosun Pharma Recent Development Table 130. Research Programs/Design for This Report Table 131. Key Data Information from Secondary Sources Table 132. Key Data Information from Primary Sources List of Figures Figure 1. Global In-Vitro Cancer Diagnostics Market Share by Type: 2020 VS 2027 Figure 2. Instruments Features Figure 3. Reagents and Kits Features Figure 4. Global In-Vitro Cancer Diagnostics Market Share by Application: 2020 VS 2027 Figure 5. Laboratories Case Studies Figure 6. Hospitals Case Studies Figure 7. Others Case Studies Figure 8. In-Vitro Cancer Diagnostics Report Years Considered Figure 9. Global In-Vitro Cancer Diagnostics Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 10. Global In-Vitro Cancer Diagnostics Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 11. Global In-Vitro Cancer Diagnostics Market Share by Regions: 2020 VS 2027 Figure 12. Global In-Vitro Cancer Diagnostics Market Share by Regions (2022-2027) Figure 13. Global In-Vitro Cancer Diagnostics Market Share by Players in 2020 Figure 14. Global Top In-Vitro Cancer Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in In-Vitro Cancer Diagnostics as of 2020 Figure 15. The Top 10 and 5 Players Market Share by In-Vitro Cancer Diagnostics Revenue in 2020 Figure 16. Global In-Vitro Cancer Diagnostics Revenue Market Share by Type (2016-2021) Figure 17. Global In-Vitro Cancer Diagnostics Revenue Market Share by Type (2022-2027) Figure 18. North America In-Vitro Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 19. North America In-Vitro Cancer Diagnostics Market Share by Type (2016-2027) Figure 20. North America In-Vitro Cancer Diagnostics Market Share by Application (2016-2027) Figure 21. North America In-Vitro Cancer Diagnostics Market Share by Country (2016-2027) Figure 22. United States In-Vitro Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 23. Canada In-Vitro Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 24. Europe In-Vitro Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 25. Europe In-Vitro Cancer Diagnostics Market Share by Type (2016-2027) Figure 26. Europe In-Vitro Cancer Diagnostics Market Share by Application (2016-2027) Figure 27. Europe In-Vitro Cancer Diagnostics Market Share by Country (2016-2027) Figure 28. Germany In-Vitro Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 29. France In-Vitro Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 30. U.K. In-Vitro Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. Italy In-Vitro Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. Russia In-Vitro Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. Nordic In-Vitro Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Asia-Pacific In-Vitro Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Asia-Pacific In-Vitro Cancer Diagnostics Market Share by Type (2016-2027) Figure 36. Asia-Pacific In-Vitro Cancer Diagnostics Market Share by Application (2016-2027) Figure 37. Asia-Pacific In-Vitro Cancer Diagnostics Market Share by Region (2016-2027) Figure 38. China In-Vitro Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 39. Japan In-Vitro Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 40. South Korea In-Vitro Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. Southeast Asia In-Vitro Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. India In-Vitro Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. Australia In-Vitro Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. Latin America In-Vitro Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Latin America In-Vitro Cancer Diagnostics Market Share by Type (2016-2027) Figure 46. Latin America In-Vitro Cancer Diagnostics Market Share by Application (2016-2027) Figure 47. Latin America In-Vitro Cancer Diagnostics Market Share by Country (2016-2027) Figure 48. Mexico In-Vitro Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 49. Brazil In-Vitro Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 50. Middle East & Africa In-Vitro Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Middle East & Africa In-Vitro Cancer Diagnostics Market Share by Type (2016-2027) Figure 52. Middle East & Africa In-Vitro Cancer Diagnostics Market Share by Application (2016-2027) Figure 53. Middle East & Africa In-Vitro Cancer Diagnostics Market Share by Country (2016-2027) Figure 54. Turkey In-Vitro Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 55. Saudi Arabia In-Vitro Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 56. UAE In-Vitro Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 57. MDx Health Quest Diagnostics Revenue Growth Rate in In-Vitro Cancer Diagnostics Business (2016-2021) Figure 58. R-Biopharm AG Revenue Growth Rate in In-Vitro Cancer Diagnostics Business (2016-2021) Figure 59. Signature Diagnostics Revenue Growth Rate in In-Vitro Cancer Diagnostics Business (2016-2021) Figure 60. Siemens Healthcare Revenue Growth Rate in In-Vitro Cancer Diagnostics Business (2016-2021) Figure 61. Randox Laboratories Revenue Growth Rate in In-Vitro Cancer Diagnostics Business (2016-2021) Figure 62. Epigenomics AG Revenue Growth Rate in In-Vitro Cancer Diagnostics Business (2016-2021) Figure 63. Beckman Coulter Revenue Growth Rate in In-Vitro Cancer Diagnostics Business (2016-2021) Figure 64. Abbott Laboratories Revenue Growth Rate in In-Vitro Cancer Diagnostics Business (2016-2021) Figure 65. Burning Rock Revenue Growth Rate in In-Vitro Cancer Diagnostics Business (2016-2021) Figure 66. Novogene Revenue Growth Rate in In-Vitro Cancer Diagnostics Business (2016-2021) Figure 67. Geneseeq Revenue Growth Rate in In-Vitro Cancer Diagnostics Business (2016-2021) Figure 68. Amoy Diagnostics Co.,Ltd. Revenue Growth Rate in In-Vitro Cancer Diagnostics Business (2016-2021) Figure 69. Daan Gene Revenue Growth Rate in In-Vitro Cancer Diagnostics Business (2016-2021) Figure 70. Fosun Pharma Revenue Growth Rate in In-Vitro Cancer Diagnostics Business (2016-2021) Figure 71. Bottom-up and Top-down Approaches for This Report Figure 72. Data Triangulation Figure 73. Key Executives Interviewed

MDx Health Quest Diagnostics R-Biopharm AG Signature Diagnostics Siemens Healthcare Randox Laboratories Epigenomics AG Beckman Coulter Abbott Laboratories Burning Rock Novogene Geneseeq Amoy Diagnostics Co.,Ltd. Daan Gene Fosun Pharma